Pedi-dri
Loading...Pedi-dri Recall
Get an alert when a recall is issued.
Questions & Answers
Side Effects & Adverse Reactions
There is currently no warning information available for this product. We apologize for any inconvenience.
Legal Issues
There is currently no legal information available for this drug.
FDA Safety Alerts
There are currently no FDA safety alerts available for this drug.
Manufacturer Warnings
There is currently no manufacturer warning information available for this drug.
FDA Labeling Changes
There are currently no FDA labeling changes available for this drug.
Uses
PEDI-DRI® is indicated in the treatment of cutaneous or mucocutaneous mycotic infections caused by Candida albicans and other susceptible Candida species.
This preparation is not indicated for systemic, oral, intravaginal or ophthalmic use.
History
There is currently no drug history available for this drug.
Other Information
PEDI-DRI®, Nystatin Topical Powder USP is for dermatologic use.
PEDI-DRI® provides, in each gram, 100,000 USP nystatin units dispersed in talc.
Nystatin is a polyene antifungal antibiotic obtained from Streptomyces nursei.
Sources
Pedi-dri Manufacturers
-
Pedinol Pharmacal, Inc.
![Pedi-dri (Nystatin) Powder [Pedinol Pharmacal, Inc.]](/wp-content/themes/bootstrap/assets/img/loading2.gif)
Pedi-dri | Pedinol Pharmacal, Inc.
Very moist lesions are best treated with the topical dusting powder.
Adults and Pediatric Patients (Neonates and Older)Apply to candidal lesions two or three times daily until healing is complete. For fungal infection of the feet caused by Candida species, the powder should be dusted on the feet, as well as, in all foot wear.
PEDI-DRI® does not stain skin or mucous membranes and provides a simple, convenient means of treatment.
Login To Your Free Account